劉玉紅

[關(guān)鍵詞] 抗精神病藥;帕羅西汀;老年抑郁癥;不良反應(yīng);生存質(zhì)量;奧氮平

[中圖分類號(hào)] R749.41? ? ? ? ? [文獻(xiàn)標(biāo)識(shí)碼] B? ? ? ? ? [文章編號(hào)] 1673-9701（2021）21-0030-04

Application value of paroxetine acid combined with low-dose atypical antipsychotics in elderly patients with depression

LIU Yuhong

Department of Psychiatry， Inner Mongolia Mental Health Center， Inner Mongolia Hohhot，? ?010010， China

[Abstract] Objective To investigate the effect of paroxetine hydrochloride combined with low-dose atypical antipsychotics in the treatment of elderly patients with depression. Methods Ninety-two elderly patients with depression treated in our hospital from January 2019 to December 2019 were selected. They were divided into the control group and the experimental group using the random number table method， with 46 patients in each group. The control group were treated with paroxetine， and the experimental group were treated with paroxetine combined with low-dose atypical antipsychotics （olanzapine）. The differences in the total effective rate， quality of life scale （HOQOL-BREF） score， anxiety self-rating scale （SAS） score， Hamilton depression scale （HAMD-17） score and adverse event scale score were compared between the two groups after 8 weeks of treatment. Results The total effective rate of patients in the experimental group （100.00%） was higher than that in the control group （73.91%）， with statistically significant difference （P<0.05）. There were no statistically significant differences in the HOQOL-BREF score， SAS score， and HAMD-17 score between the two groups before treatment （P>0.05）. There were no statistically significant differences in the HOQOL-BREF score， SAS score and HAMD-17 score between the two groups after treatment （P<0.05）. There was no statistically significant difference in the adverse event scale score between the two groups （P>0.05）. Conclusion Paroxetine combined with olanzapine can be considered as the treatment for elderly patients with depression. It can effectively improve the quality of life of patients and is worthy of application.

[Key words] Antipsychotics; Paroxetine; Elderly depression; Adverse event; Quality of life; Olanzapine

抑郁癥屬于臨床上常見(jiàn)的一種心理障礙疾病，其病因復(fù)雜多樣，主要表現(xiàn)為情緒低落、失眠多夢(mèng)甚至絕望自殺，具有較高的發(fā)病率[1]。隨著近年來(lái)社會(huì)不斷發(fā)展，在日常工作和生活中人們面臨的壓力越來(lái)越大，使得抑郁癥在我國(guó)的發(fā)病率不斷上升[2]。此外，我國(guó)正在逐步進(jìn)入老齡化社會(huì)，導(dǎo)致老年人口有所增加，老年抑郁癥發(fā)生率也呈上升趨勢(shì)，通常老年患者的抑郁癥狀不典型，病程較長(zhǎng)，很容易發(fā)展為慢性病[3]。目前，藥物干預(yù)是臨床治療抑郁癥的主要手段之一，可以有效緩解患者的不良心理情緒，改善抑郁行為，提高生活質(zhì)量[4]。帕羅西汀是目前精神科比較常用的新型抗抑郁劑，臨床上應(yīng)用較多[5]。近些年來(lái)，非典型抗精神病藥物已逐漸作為首選藥物廣泛應(yīng)用于各類精神疾病的治療，尤其是用于初發(fā)病患者，其中又以?shī)W氮平最受歡迎，奧氮平主要用于治療精神分裂癥[6]。因此，選取研究病例為我院老年抑郁癥患者，將上述藥物應(yīng)用其中，現(xiàn)報(bào)道如下。